Ascletis Reports Positive Preclinical Data For Once-Weekly Oral Obesity Drug Pipeline
(RTTNews) - Ascletis Pharma Inc. (1672.HK) announced positive preclinical data for its once-weekly oral peptide pipeline targeting obesity and other metabolic diseases, highlighting extended half-lives and oral bioavailability.